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A Case Report Discussing The Options for Placement of Glaucoma Drainage Devices in the Presence of
Corneal Decompensation
Purpose: The purpose of this case report is to discuss how the various placements of glaucoma drainage
implants relate to corneal decompensation. Method: A 58-year Hispanic female presented for evaluation of
decreased vision in the left eye for 2 years. This is a case report of a patient who underwent a secondary surgery
to replace the anterior tube shunt implantation with a posterior shunt implantation following development
of severe corneal decompensation. Results: Glaucoma tube shunt implants inserted into the ciliary sulcus of
pseudophakic eyes shield the cornea offering protection against decompensation and avoid the risk of posterior
segment complications.
Conclusions: Placement of glaucoma drainage implants into the ciliary sulcus in pseudophakic patients with
shallow anterior chambers, abnormal irido-corneal anatomy, or those at risk for corneal decompensation is a
safe and effective method of not only lowering the intraocular pressure but also protecting the cornea against
decompensation. As primary eye care providers, optometrists need to know the various treatment options and
adverse effects associated with each procedure.
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Purpose: The purpose of this case report is to discuss how the various placements of glaucoma drainage implants relate to 
corneal decompensation. Method: A 58-year Hispanic female presented for evaluation of decreased vision in the left eye for 2 
years. This is a case report of a patient who underwent a secondary surgery to replace the anterior tube shunt implantation with 
a posterior shunt implantation following development of severe corneal decompensation. Results: Glaucoma tube shunt 
implants inserted into the ciliary sulcus of pseudophakic eyes shield the cornea offering protection against decompensation and 
avoid the risk of posterior segment complications. Conclusions: Placement of glaucoma drainage implants into the ciliary sulcus 
in pseudophakic patients with shallow anterior chambers, abnormal irido-corneal anatomy, or those at risk for corneal 
decompensation is a safe and effective method of not only lowering the intraocular pressure but also protecting the cornea 
against decompensation. As primary eye care providers, optometrists need to know the various treatment options and adverse 
effects associated with each procedure. 
 
Introduction 
Management of refractory glaucoma is challenging because classic treatment with ophthalmic medications or glaucoma filtering 
procedures is ineffective in controlling high intraocular pressure (IOP). Historically, implantation of glaucoma drainage devices 
(GDIs) have been used in order to obtain sufficiently low IOP in cases of refractory glaucoma. Glaucoma tube shunt implants 
can be placed in several sites within the eye: the irido-corneal angle, the posterior vitreous, or the ciliary sulcus. Because anterior 
chamber shunts avoid the need for vitrectomy, they are the primary surgical location when deciding to insert these implants, 
though 9.7% to 20.75% develop corneal edema following this procedure.1-4 Studies indicate that posterior tube implantation in 
the ciliary sulcus can be an effective treatment option for patients who develop corneal decompensation following anterior 
chamber shunt implantation.5 This is a case report of a patient who developed severe corneal decompensation after initial 
implantation of the glaucoma tube shunt in the irido-corneal angle. The patient subsequently underwent penetrating keratoplasty 
(PKP) and an additional surgery to have the tube re-positioned in the ciliary sulcus to prevent subsequent decompensation of 
the corneal transplant.  
 
Case Report 
A 58-year old Hispanic female presented for evaluation of decreased vision in the left eye over the past 2 years. Ocular history 
revealed glaucoma and pseudophakia in both eyes as well as a corneal transplant in the left eye.  
 
Ocular surgical history was positive for phacoemulsification in both eyes in 2003, trabeculectomy in both eyes in 2007, and irido-
corneal angle tube implantation in the left eye in 2007. The patient reported the cornea in her left eye decompensated because 
of the implantation of the shunt into the irido-corneal angle in 2007. As a result of the corneal endothelial failure, the shunt was 
removed from the irido-corneal angle. In order to prevent decompensation of the donor cornea, insertion of the shunt in the 
ciliary sulcus was recommended and performed. In 2007, the patient underwent penetrating keratoplasty, vitrectomy and 
implantation of the shunt into the ciliary sulcus.  
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At the time of the initial visit, the patient was using Pred Forte (prednisolone acetate) 1% ophthalmic suspension BID OS and 
Xalatan (latanoprost) 0.005% ophthalmic solution qhs OU. Best-corrected visual acuity was 20/25 OD and 20/100 OS. Pupils 
were irregularly shaped in both eyes, with 2+ reaction to light OD and no reaction to light OS. Biomicroscopy of the right eye 
revealed a superior clear, filtering bleb with negative Seidel’s sign. Biomicroscopy of the left eye revealed a superior flat bleb, 
corneal graft with intact sutures, and areas of microcystic edema, posterior chamber intraocular lens, which appeared clear and 
centered with an open posterior capsule and an unobstructed tube positioned within the ciliary sulcus. See figures 1 and 2.  
 
The intraocular pressure was measured by Goldmann applanation tonometry and recorded as 13 mmHg OD and 07 mmHg OS 
at 3:16 pm. Dilated fundus examination of the right eye showed a clear vitreous. The optic nerves were pink and distinct in both 
eyes and had a 0.35/0.35 and 0.4/0.4 cup-to-disc ratio, right and left eye respectively. The maculae, vessels, and peripheral 
retina were all within normal limits in the right eye. The left eye had a fixed, miotic pupil and corneal edema, so our views of the 
posterior pole were limited, and the periphery could not be assessed.  
 
The patient’s diagnoses were open angle glaucoma in both eyes, status post trabeculectomy in both eyes that failed in the left 
eye, status post penetrating keratoplasty in the left eye for corneal decompensation secondary to anterior chamber tube shunt, 
and status post vitrectomy and tube shunt replacement in the ciliary sulcus in the left eye.  
 
Figure 1: External photograph of the left eye revealing corneal graft with intact sutures and edema. Arrow is pointing to the 
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Traditionally, the silicone tube of the glaucoma drainage device was placed in the anterior chamber. Introduction of the shunt 
into the anterior chamber is complicated by tube-corneal touch in 8% to 20% of patients and causes problems with corneal 
decompensation in 17% to 19% of patients.6,7 This is especially problematic in patients with pre-existing corneal disease (i.e. 
corneal edema, endothelial corneal dystrophy, Fuchs corneal dystrophy), corneal transplants, and shallow anterior chambers 
and abnormal irido-corneal angle anatomy.8 Placement of a shunt into the irido-corneal angle is preferred over the posterior 
chamber because it avoids the need for a vitrectomy. However, in patients with high risk for corneal decompensation, the pars 
plana approach, where the tube shunt is placed into the posterior chamber away from the cornea, has shown to be beneficial in 
controlling IOP and preserving vision.9 
 
When the glaucoma drainage tube is placed into the pars plana, a pars plana vitrectomy is required. This procedure is performed 
to prevent vitreous from occluding the tube lumen. In cases of tube occlusion by vitreous remnants, Nd:YAG laser 
membranectomy may be performed to reopen the blocked tube shunt. Subsequent re-blockage within 2 months has been 
reported in 54% of cases.9 However, placement of the tube into the pars plana is also associated with corneal decompensation 
as well as posterior segment complications, such as epiretinal membranes and retinal detachments. It requires two procedures 
leading to increased surgical risks, increased costs, and complicated logistics of coordinating and scheduling both surgeries.10 
Decreased risk of both corneal decompensation and posterior segment complications are considered significant advantages of 
implanting the glaucoma tube shunt in the ciliary sulcus.11  
Eyes with shallow to moderate anterior chambers are at risk for developing corneal decompensation because of intermediate or 
continuous cornea-tube touch.11 When the tube is implanted into the irido-corneal angle of an eye with a shallow or moderate 
anterior chamber, the tube rests too closely to the corneal endothelium, and the cornea is subjected to decompensating. In 
cases where the tube may not be in continuous contact with the cornea, intermittent corneal endothelial damage may occur from 
anteriorly placed tubes during eye rubbing, sneezing, or even blinking.11 The ciliary sulcus is enclosed by the iris pigmented 
epithelium anteriorly, the ciliary processes posteriorly, and the anterior zonular fibers and lens capsule centrally. Implantation of 
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the tube shunt in the ciliary sulcus of pseudophakic patients allows shielding of the cornea as the tube rests against the posterior 
surface of the intraocular lens.11  
 
Most commonly reported postoperative complications associated with placing glaucoma drainage devices in the ciliary sulcus 
are small hyphemas and self-limiting serous choroidal detachments.11 Positioning the tube in the ciliary sulcus carries an 
increased risk of obstruction by the iris. However; should this occur, it can be remedied by in-office laser iridotomy.12 Ciliary 
sulcus tube shunts have not been associated with IOL dislocation, pigment dispersion, or significant loss of vision as a result of 
the procedure.9 Neither ciliary body separation nor suprachoroidal hemorrhage have been encountered in this procedure.13 
Insertion of the tube shunt in the ciliary sulcus is contraindicated in phakic eyes, as the integrity of the crystalline lens may 
become compromised.13 The procedure can also be performed in the presence of an anterior chamber intraocular lens. A major 
advantage of this procedure is the tube rests behind the intraocular implant13 Studies have shown that tube insertion in the ciliary 
sulcus in pseudophakic eyes is considered to be safe and effective at lowering intraocular pressure and lowers the risk of 
subsequent corneal decompensation.13-16 
 
Conclusion  
In summary, there are various methods for lowering intraocular pressure, including pharmacological, laser and surgical.17-19 In 
cases of refractory glaucoma, where conventional treatment with ophthalmic medications and trabeculectomy failed, glaucoma 
drainage device implantation is performed. As both anterior and posterior vitreous placement of the glaucoma drainage devices 
can result in post-surgical complications of corneal decompensation, alternative options have been employed. Tube shunt 
implant positioning in the ciliary sulcus serves as a safe and effective option for patients who developed corneal decompensation 
following anterior chamber tube shunt placement, those who are at risk for developing corneal decompensation, and those with 
high risk for complications during a pars plana vitrectomy. As primary eye care providers, optometrists need to understand the 
various treatment options and adverse effects associated with each procedure, specifically when it comes to placement of 
glaucoma drainage devices. 
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